Defunct Company
Total Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
326
NCT05194475
Metabolic Effects of a Thermogenic Ready-to-drink Beverage
Phase: N/A
Role: Collaborator
Start: Jan 18, 2022
Completion: May 6, 2022
NCT05619809
Chronic Thermogenic Dietary Supplement Consumption
Start: Jan 17, 2023
Completion: May 15, 2023
NCT07077681
Evaluation of the Acceptability and Therapeutic Maintenance After Substitution of Ustekinumab With a Biosimilar
Role: Lead Sponsor
Start: Jun 2, 2025
Completion: Dec 31, 2027